Building Bridges: The Impact of Medical Science Liaison and Advanced Practice Provider Collaborations - Takeaways - MDSpire

Building Bridges: The Impact of Medical Science Liaison and Advanced Practice Provider Collaborations

Share

  • 1

    Collaboration between medical science liaisons (MSLs) and advanced practice providers (APPs) enhances cancer care through education and research.

  • 2

    MSLs provide tailored education and support clinical trials, enabling APPs to make informed decisions and improve patient outcomes.

  • 3

    The MSL role, established in 1967, has evolved to include clinical trial support and medical education, distinct from commercial sales.

  • 4

    MSLs operate in a non-promotional capacity, delivering unbiased, evidence-based information while adhering to compliance standards.

  • 5

    Effective MSL-APP partnerships focus on clinical research, medical education, and insight gathering, bridging scientific innovation and clinical application.

Original Source(s)

Building Bridges: The Impact of Medical Science Liaison and Advanced Practice Provider Collaborations

  • by Katherine Albert, Kristina Byers, Chelsey Boggs

  • May 6, 2026

Related Content

This Week’s Biopharma News: EU Clears First Pertuzumab Biosimilar

Plus: NICE backs rozanolixizumab for uncontrolled gMG, Genexine reports SOX2 degrader data, and BeOne secures option on Huahui trispecific antibody

  • May 5, 2026

  • 5 min
COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings

Patients diagnosed with metastatic breast cancer and non–small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according ...

Zoldonrasib in Patients With <em>KRAS</em> G12D–Mutant NSCLC Previously Treated With Chemoimmunotherapy

The investigational KRAS G12D inhibitor zoldonrasib had a favorable safety profile and induced antitumor activity in some patients with KRAS G12D–mutated non–small cell lung cancer (NSCLC) who were pr...